Siegfried Holding AG Share Price Berne S.E.

Equities

SFZN

CH0014284498

Pharmaceuticals

Real-time Estimate Cboe Europe 02:47:35 29/05/2024 pm IST 5-day change 1st Jan Change
875.5 CHF 0.00% Intraday chart for Siegfried Holding AG 0.00% 0.00%

Financials

Sales 2024 * 130.25Cr 142.68Cr 12TCr Sales 2025 * 142.19Cr 155.76Cr 13TCr Capitalization 377.03Cr 413.01Cr 34TCr
Net income 2024 * 15Cr 16Cr 1.35TCr Net income 2025 * 17Cr 19Cr 1.57TCr EV / Sales 2024 * 3.16 x
Net Debt 2024 * 35Cr 38Cr 3.2TCr Net Debt 2025 * 31Cr 34Cr 2.86TCr EV / Sales 2025 * 2.87 x
P/E ratio 2024 *
25.4 x
P/E ratio 2025 *
21.8 x
Employees -
Yield 2024 *
0.44%
Yield 2025 *
0.46%
Free-Float 87.68%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 53 01/17/01
Chief Tech/Sci/R&D Officer 56 01/19/01
Corporate Officer/Principal - 01/14/01
Members of the board TitleAgeSince
Director/Board Member 55 01/16/01
Director/Board Member 63 01/14/01
Chairman 61 01/10/01
More insiders
Siegfried Holding AG is a Switzerland-based life sciences company which is active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and sterile. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States, China, and Spain.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
879 CHF
Average target price
1,016 CHF
Spread / Average Target
+15.57%
Consensus